表紙
市場調查報告書

葡萄膜炎治療的全球市場:各類藥物,各疾病類型,各流通管道,各地區的產業分析與預測(2019年∼2025年)

Global Uveitis Treatment Market By Drug Class By Disease Type By Distribution Channel By Region, Industry Analysis and Forecast, 2019 - 2025

出版商 KBV Research 商品編碼 932516
出版日期 內容資訊 英文 214 Pages
訂單完成後即時交付
價格
葡萄膜炎治療的全球市場:各類藥物,各疾病類型,各流通管道,各地區的產業分析與預測(2019年∼2025年) Global Uveitis Treatment Market By Drug Class By Disease Type By Distribution Channel By Region, Industry Analysis and Forecast, 2019 - 2025
出版日期: 2020年03月31日內容資訊: 英文 214 Pages
簡介

葡萄膜炎,是由虹膜、脈絡膜、睫狀體組成的葡萄膜壁中間組織層的發炎,有前部葡萄膜炎,中部葡萄膜炎,後部葡萄膜炎,泛葡萄膜炎。治療使用抗發炎藥,睫狀體筋麻痺藥,抗菌藥,免疫療法,標靶治療等各種方法,雖然關於病因和病理生理學依然不明確,但是治療藥的市場規模,至2025年預計將以5.5%的年複合成長率繼續成長,達到6億8,610萬美元的規模。

本報告提供全球葡萄膜炎治療藥的市場調查,各類藥物,各疾病類型,各流通管道,各地區的分析,企業簡介等資訊。

目錄

第1章 市場範圍和調查方法

  • 市場定義
  • 目的
  • 市場範圍
  • 市場區隔
  • 調查方法

第2章 市場概要

  • 簡介
  • 影響市場的主要原因

第3章 藥物的各類型的市場分析

  • 抗發炎藥
  • 免疫療法和標靶治療
  • 抗菌藥
  • 其他

第4章 各疾病類型的市場分析

  • 前部葡萄膜炎
  • 後部葡萄膜炎
  • 中間部葡萄膜炎
  • 其他

第5章 各流通管道的市場分析

  • 醫院的藥局
  • 零售藥局
  • 線上藥局

第6章 各地區的市場分析

  • 北美
  • 歐洲
  • 亞太地區
  • 南美、中東、非洲

第7章 企業簡介

  • AbbVie, Inc.
  • Alimera Sciences, Inc.
  • Enzo Biochem, Inc.
  • Amgen, Inc.
  • Bausch Health Companies, Inc.
  • Clearside Biomedical, Inc.
  • EyePoint Pharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • Topivert Ltd.
  • Novartis AG
目錄

The Global Uveitis Treatment Market size is expected to reach $686.1 Million by 2025, rising at a market growth of 5.5% CAGR during the forecast period. Uveitis is the inflammation of the middle tissue layer in the uvea eyewall which consists of the iris, choroid, and ciliary body. Various drug formulations such as anti-inflammatory drugs, cycloplegic agents, antimicrobial drugs, immunotherapy & targeted therapies, and others are used for uveitis treatment. These involve anterior uveitis, intermediate uveitis, posterior uveitis, and panuveitis. Inflammation of the iris called iritis or anterior uveitis is the most prevalent form of uveitis.

Increased prevalence of uveitis and growing awareness among the patient population with increased acceptance of innovative treatments is expected to drive the growth of the market. In addition, convenient access to uveitis treatment, increased demand for uveitis medications, and a boom in R&D activities to improve ideal uveitis treatment to further drive the growth of the industry.

Nevertheless, it is anticipated that the uncertain etiology and pathophysiology of uveitis would hinder market development. In addition, untapped capacity offered by emerging economies is presenting lucrative opportunities for market growth over the forecast period. Nonetheless, there is likely to be a shortage of effective treatment for uveitis disorder to limit the market growth.

Uveitis is considered the leading cause of blindness in the United States, with a steady rise in prevalence. Corticosteroid is considered the first-line treatment for uveitis. A large number of compounds for treating uveitis are lined up in growth. Leading industry players are adding new drugs to improve their product portfolio. The procedure for the sterile formulations, however, is highly complex and businesses are likely to align themselves with the GMP and regulatory requirements for producing their products.

Based on Drug Class, the market is segmented into Anti-inflammatory, Immunotherapy & Targeted Therapies, Antimicrobial Drugs and Other Drug Class. Based on Disease Type, the market is segmented into Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis and Panuveitis. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online stores. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Alimera Sciences, Inc., Enzo Biochem, Inc., Amgen, Inc., Bausch Health Companies, Inc., Clearside Biomedical, Inc., EyePoint Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., TopiVert Ltd., and Novartis AG.

Strategies deployed in Uveitis Treatment Market

Mar-2020: Clearside Biomedical announced an agreement with Arctic Vision, a company focused on developing and commercializing innovative ophthalmology therapies in China and Asia. Under this agreement, the latter company has acquired an exclusive license for the commercialization and development of XIPERE (triamcinolone acetonide suprachoroidal injectable suspension) in Greater China (mainland China, Hong Kong, Macau and Taiwan) and South Korea.

Feb-2020: Santen Pharmaceutical signed an agreement with Verily, an Alphabet company. Following the agreement, the companies would establish a joint venture focused on applying microelectronics and scalable digital technologies to ophthalmology.

Oct-2019: Bausch Health Ireland signed an agreement with Clearside Biomedical. The agreement granted Bausch with an exclusive license for developing, manufacturing, distributing, promoting, marketing, and commercializing the suprachoroidal injection device.

Sep-2019: Alimera Sciences launched ILUVIEN in Germany. This solution has been used in prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye (NIPU).

Jul-2019: Novartis completed the acquisition of Xiidra (lifitegrast ophthalmic solution), the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation caused by the disease. The acquisition enabled the company to deliver medicine for patients suffering from a variety of eye diseases.

Mar-2019: Novartis got FDA approval for Mayzent (siponimod), a new solution for the treatment of relapsing forms of multiple sclerosis (RMS).

Feb-2019: EyePoint Pharmaceuticals released the Yutiq, a 3-year micro-insert for the treatment of chronic noninfectious uveitis, which affects the posterior segment of the eye. The company also announced the launch of EyePoint Assist, a program for ensuring access to Yutiq for eligible patients in need of financial assistance.

Oct-2018: Amgen introduced Amgevita in Europe. This therapy is available in the 28 countries of the European Union, plus Norway, Iceland, and Liechtenstein. Amgevita is a human antibody that has been designed for targeting the human tumor necrosis factor alpha (TNFα), an immune factor that regulates the inflammatory response.

Mar-2018: pSivida acquired Icon Bioscience and its FDA-approved dexamethasone intraocular suspension designed to treat postoperative inflammation. Following the acquisition, both the companies have combined their businesses and started doing business as EyePoint Pharmaceuticals.

Jul-2016: AbbVie got FDA approval for Humira, a new therapy for non-infectious intermediate, posterior, and panuveitis. This is a non-corticosteroid treatment option for certain types of uveitis, an eye disease that can flare and impact vision.

Scope of the Study

Market Segmentation:

By Drug Class

Anti-inflammatory

Immunotherapy & Targeted Therapies

Antimicrobial Drugs

Other Drug Class

By Disease Type

Anterior Uveitis

Posterior Uveitis

Intermediate Uveitis

Panuveitis

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies

Online stores

By Geography

North America

US

Canada

Mexico

Rest of North America

Europe

Germany

UK

France

Russia

Spain

Italy

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Singapore

Malaysia

Rest of Asia Pacific

LAMEA

Brazil

Argentina

UAE

Saudi Arabia

South Africa

Nigeria

Rest of LAMEA

Companies Profiled

AbbVie, Inc.

Alimera Sciences, Inc.

Enzo Biochem, Inc.

Amgen, Inc.

Bausch Health Companies, Inc.

Clearside Biomedical, Inc.

EyePoint Pharmaceuticals, Inc.

Santen Pharmaceutical Co., Ltd.

TopiVert Ltd.

Novartis AG

Unique Offerings from KBV Research

Exhaustive coverage

Highest number of market tables and figures

Subscription based model available

Guaranteed best price

Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Uveitis Treatment Market, by Drug Class
    • 1.4.2 Global Uveitis Treatment Market, by Disease Type
    • 1.4.3 Global Uveitis Treatment Market, by Distribution Channel
    • 1.4.4 Global Uveitis Treatment Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Uveitis Treatment Market by Drug Class

  • 3.1 Global Anti-inflammatory Market by Region
  • 3.2 Global Immunotherapy & Targeted Therapies Market by Region
  • 3.3 Global Antimicrobial Drugs Market by Region
  • 3.4 Global Other Drug Class Market by Region

Chapter 4. Global Uveitis Treatment Market by Disease Type

  • 4.1 Global Anterior Uveitis Market by Region
  • 4.2 Global Posterior Uveitis Market by Region
  • 4.3 Global Intermediate Uveitis Market by Region
  • 4.4 Global Other Diseases Market by Region

Chapter 5. Global Uveitis Treatment Market by Distribution Channel

  • 5.1 Global Hospital Pharmacies Market by Region
  • 5.2 Global Retail Pharmacies Market by Region
  • 5.3 Global Online stores Market by Region

Chapter 6. Global Uveitis Treatment Market by Region

  • 6.1 North America Uveitis Treatment Market
    • 6.1.1 North America Uveitis Treatment Market by Drug Class
      • 6.1.1.1 North America Anti-inflammatory Market by Country
      • 6.1.1.2 North America Immunotherapy & Targeted Therapies Market by Country
      • 6.1.1.3 North America Antimicrobial Drugs Market by Country
      • 6.1.1.4 North America Other Drug Class Market by Country
    • 6.1.2 North America Uveitis Treatment Market by Disease Type
      • 6.1.2.1 North America Anterior Uveitis Market by Country
      • 6.1.2.2 North America Posterior Uveitis Market by Country
      • 6.1.2.3 North America Intermediate Uveitis Market by Country
      • 6.1.2.4 North America Other Disease Types Market by Country
    • 6.1.3 North America Uveitis Treatment Market by Distribution Channel
      • 6.1.3.1 North America Hospital Pharmacies Market by Country
      • 6.1.3.2 North America Retail Pharmacies Market by Country
      • 6.1.3.3 North America Online stores Market by Country
    • 6.1.4 North America Uveitis Treatment Market by Country
      • 6.1.4.1 USA Uveitis Treatment Market
        • 6.1.4.1.1 USA Uveitis Treatment Market by Drug Class
        • 6.1.4.1.2 USA Uveitis Treatment Market by Disease Type
        • 6.1.4.1.3 USA Uveitis Treatment Market by Distribution Channel
      • 6.1.4.2 Canada Uveitis Treatment Market
        • 6.1.4.2.1 Canada Uveitis Treatment Market by Drug Class
        • 6.1.4.2.2 Canada Uveitis Treatment Market by Disease Type
        • 6.1.4.2.3 Canada Uveitis Treatment Market by Distribution Channel
      • 6.1.4.3 Mexico Uveitis Treatment Market
        • 6.1.4.3.1 Mexico Uveitis Treatment Market by Drug Class
        • 6.1.4.3.2 Mexico Uveitis Treatment Market by Disease Type
        • 6.1.4.3.3 Mexico Uveitis Treatment Market by Distribution Channel
      • 6.1.4.4 Rest of North America Uveitis Treatment Market
        • 6.1.4.4.1 Rest of North America Uveitis Treatment Market by Drug Class
        • 6.1.4.4.2 Rest of North America Uveitis Treatment Market by Disease Type
        • 6.1.4.4.3 Rest of North America Uveitis Treatment Market by Distribution Channel
  • 6.2 Europe Uveitis Treatment Market
    • 6.2.1 Europe Uveitis Treatment Market by Drug Class
      • 6.2.1.1 Europe Anti-inflammatory Market by Country
      • 6.2.1.2 Europe Immunotherapy & Targeted Therapies Market by Country
      • 6.2.1.3 Europe Antimicrobial Drugs Market by Country
      • 6.2.1.4 Europe Other Drug Class Market by Country
    • 6.2.2 Europe Uveitis Treatment Market by Disease Type
      • 6.2.2.1 Europe Anterior Uveitis Market by Country
      • 6.2.2.2 Europe Posterior Uveitis Market by Country
      • 6.2.2.3 Europe Intermediate Uveitis Market by Country
      • 6.2.2.4 Europe Other Diseases Market by Country
    • 6.2.3 Europe Uveitis Treatment Market by Distribution Channel
      • 6.2.3.1 Europe Hospital Pharmacies Market by Country
      • 6.2.3.2 Europe Retail Pharmacies Market by Country
      • 6.2.3.3 Europe Online stores Market by Country
    • 6.2.4 Europe Uveitis Treatment Market by Country
      • 6.2.4.1 Germany Uveitis Treatment Market
        • 6.2.4.1.1 Germany Uveitis Treatment Market by Drug Class
        • 6.2.4.1.2 Germany Uveitis Treatment Market by Disease Type
        • 6.2.4.1.3 Germany Uveitis Treatment Market by Distribution Channel
      • 6.2.4.2 UK Uveitis Treatment Market
        • 6.2.4.2.1 UK Uveitis Treatment Market by Drug Class
        • 6.2.4.2.2 UK Uveitis Treatment Market by Disease Type
        • 6.2.4.2.3 UK Uveitis Treatment Market by Distribution Channel
      • 6.2.4.3 France Uveitis Treatment Market
        • 6.2.4.3.1 France Uveitis Treatment Market by Drug Class
        • 6.2.4.3.2 France Uveitis Treatment Market by Disease Type
        • 6.2.4.3.3 France Uveitis Treatment Market by Distribution Channel
      • 6.2.4.4 Russia Uveitis Treatment Market
        • 6.2.4.4.1 Russia Uveitis Treatment Market by Drug Class
        • 6.2.4.4.2 Russia Uveitis Treatment Market by Disease Type
        • 6.2.4.4.3 Russia Uveitis Treatment Market by Distribution Channel
      • 6.2.4.5 Spain Uveitis Treatment Market
        • 6.2.4.5.1 Spain Uveitis Treatment Market by Drug Class
        • 6.2.4.5.2 Spain Uveitis Treatment Market by Disease Type
        • 6.2.4.5.3 Spain Uveitis Treatment Market by Distribution Channel
      • 6.2.4.6 Italy Uveitis Treatment Market
        • 6.2.4.6.1 Italy Uveitis Treatment Market by Drug Class
        • 6.2.4.6.2 Italy Uveitis Treatment Market by Disease Type
        • 6.2.4.6.3 Italy Uveitis Treatment Market by Distribution Channel
      • 6.2.4.7 Rest of Europe Uveitis Treatment Market
        • 6.2.4.7.1 Rest of Europe Uveitis Treatment Market by Drug Class
        • 6.2.4.7.2 Rest of Europe Uveitis Treatment Market by Disease Type
        • 6.2.4.7.3 Rest of Europe Uveitis Treatment Market by Distribution Channel
  • 6.3 Asia Pacific Uveitis Treatment Market
    • 6.3.1 Asia Pacific Uveitis Treatment Market by Drug Class
      • 6.3.1.1 Asia Pacific Anti-inflammatory Market by Country
      • 6.3.1.2 Asia Pacific Immunotherapy & Targeted Therapies Market by Country
      • 6.3.1.3 Asia Pacific Antimicrobial Drugs Market by Country
      • 6.3.1.4 Asia Pacific Other Drug Class Market by Country
    • 6.3.2 Asia Pacific Uveitis Treatment Market by Disease Type
      • 6.3.2.1 Asia Pacific Anterior Uveitis Market by Country
      • 6.3.2.2 Asia Pacific Posterior Uveitis Market by Country
      • 6.3.2.3 Asia Pacific Intermediate Uveitis Market by Country
      • 6.3.2.4 Asia Pacific Other Diseases Market by Country
    • 6.3.3 Asia Pacific Uveitis Treatment Market by Distribution Channel
      • 6.3.3.1 Asia Pacific Hospital Pharmacies Market by Country
      • 6.3.3.2 Asia Pacific Retail Pharmacies Market by Country
      • 6.3.3.3 Asia Pacific Online stores Market by Country
    • 6.3.4 Asia Pacific Uveitis Treatment Market by Country
      • 6.3.4.1 China Uveitis Treatment Market
        • 6.3.4.1.1 China Uveitis Treatment Market by Drug Class
        • 6.3.4.1.2 China Uveitis Treatment Market by Disease Type
        • 6.3.4.1.3 China Uveitis Treatment Market by Distribution Channel
      • 6.3.4.2 Japan Uveitis Treatment Market
        • 6.3.4.2.1 Japan Uveitis Treatment Market by Drug Class
        • 6.3.4.2.2 Japan Uveitis Treatment Market by Disease Type
        • 6.3.4.2.3 Japan Uveitis Treatment Market by Distribution Channel
      • 6.3.4.3 India Uveitis Treatment Market
        • 6.3.4.3.1 India Uveitis Treatment Market by Drug Class
        • 6.3.4.3.2 India Uveitis Treatment Market by Disease Type
        • 6.3.4.3.3 India Uveitis Treatment Market by Distribution Channel
      • 6.3.4.4 South Korea Uveitis Treatment Market
        • 6.3.4.4.1 South Korea Uveitis Treatment Market by Drug Class
        • 6.3.4.4.2 South Korea Uveitis Treatment Market by Disease Type
        • 6.3.4.4.3 South Korea Uveitis Treatment Market by Distribution Channel
      • 6.3.4.5 Singapore Uveitis Treatment Market
        • 6.3.4.5.1 Singapore Uveitis Treatment Market by Drug Class
        • 6.3.4.5.2 Singapore Uveitis Treatment Market by Disease Type
        • 6.3.4.5.3 Singapore Uveitis Treatment Market by Distribution Channel
      • 6.3.4.6 Malaysia Uveitis Treatment Market
        • 6.3.4.6.1 Malaysia Uveitis Treatment Market by Drug Class
        • 6.3.4.6.2 Malaysia Uveitis Treatment Market by Disease Type
        • 6.3.4.6.3 Malaysia Uveitis Treatment Market by Distribution Channel
      • 6.3.4.7 Rest of Asia Pacific Uveitis Treatment Market
        • 6.3.4.7.1 Rest of Asia Pacific Uveitis Treatment Market by Drug Class
        • 6.3.4.7.2 Rest of Asia Pacific Uveitis Treatment Market by Disease Type
        • 6.3.4.7.3 Rest of Asia Pacific Uveitis Treatment Market by Distribution Channel
  • 6.4 LAMEA Uveitis Treatment Market
    • 6.4.1 LAMEA Uveitis Treatment Market by Drug Class
      • 6.4.1.1 LAMEA Anti-inflammatory Market by Country
      • 6.4.1.2 LAMEA Immunotherapy & Targeted Therapies Market by Country
      • 6.4.1.3 LAMEA Antimicrobial Drugs Market by Country
      • 6.4.1.4 LAMEA Other Drug Class Market by Country
    • 6.4.2 LAMEA Uveitis Treatment Market by Disease Type
      • 6.4.2.1 LAMEA Anterior Uveitis Market by Country
      • 6.4.2.2 LAMEA Posterior Uveitis Market by Country
      • 6.4.2.3 LAMEA Intermediate Uveitis Market by Country
      • 6.4.2.4 LAMEA Other Diseases Market by Country
    • 6.4.3 LAMEA Uveitis Treatment Market by Distribution Channel
      • 6.4.3.1 LAMEA Hospital Pharmacies Market by Country
      • 6.4.3.2 LAMEA Retail Pharmacies Market by Country
      • 6.4.3.3 LAMEA Online stores Market by Country
    • 6.4.4 LAMEA Uveitis Treatment Market by Country
      • 6.4.4.1 Brazil Uveitis Treatment Market
        • 6.4.4.1.1 Brazil Uveitis Treatment Market by Drug Class
        • 6.4.4.1.2 Brazil Uveitis Treatment Market by Disease Type
        • 6.4.4.1.3 Brazil Uveitis Treatment Market by Distribution Channel
      • 6.4.4.2 Argentina Uveitis Treatment Market
        • 6.4.4.2.1 Argentina Uveitis Treatment Market by Drug Class
        • 6.4.4.2.2 Argentina Uveitis Treatment Market by Disease Type
        • 6.4.4.2.3 Argentina Uveitis Treatment Market by Distribution Channel
      • 6.4.4.3 UAE Uveitis Treatment Market
        • 6.4.4.3.1 UAE Uveitis Treatment Market by Drug Class
        • 6.4.4.3.2 UAE Uveitis Treatment Market by Disease Type
        • 6.4.4.3.3 UAE Uveitis Treatment Market by Distribution Channel
      • 6.4.4.4 Saudi Arabia Uveitis Treatment Market
        • 6.4.4.4.1 Saudi Arabia Uveitis Treatment Market by Drug Class
        • 6.4.4.4.2 Saudi Arabia Uveitis Treatment Market by Disease Type
        • 6.4.4.4.3 Saudi Arabia Uveitis Treatment Market by Distribution Channel
      • 6.4.4.5 South Africa Uveitis Treatment Market
        • 6.4.4.5.1 South Africa Uveitis Treatment Market by Drug Class
        • 6.4.4.5.2 South Africa Uveitis Treatment Market by Disease Type
        • 6.4.4.5.3 South Africa Uveitis Treatment Market by Distribution Channel
      • 6.4.4.6 Nigeria Uveitis Treatment Market
        • 6.4.4.6.1 Nigeria Uveitis Treatment Market by Drug Class
        • 6.4.4.6.2 Nigeria Uveitis Treatment Market by Disease Type
        • 6.4.4.6.3 Nigeria Uveitis Treatment Market by Distribution Channel
      • 6.4.4.7 Rest of LAMEA Uveitis Treatment Market
        • 6.4.4.7.1 Rest of LAMEA Uveitis Treatment Market by Drug Class
        • 6.4.4.7.2 Rest of LAMEA Uveitis Treatment Market by Disease Type
        • 6.4.4.7.3 Rest of LAMEA Uveitis Treatment Market by Distribution Channel

Chapter 7. Company Profiles

  • 7.1 AbbVie, Inc.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Regional Analysis
    • 7.1.4 Research & Development Expenses
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Approvals:
  • 7.2 Alimera Sciences, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.1 Recent strategies and developments:
      • 7.2.1.1 Product Launches and Product Expansions:
  • 7.3 Enzo Biochem, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental and Regional Analysis
    • 7.3.4 Research & Development Expense
  • 7.4 Amgen, Inc.
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Research & Development Expense
    • 7.4.4 Recent strategies and developments:
      • 7.4.4.1 Product Launches and Product Expansions:
      • 7.4.4.2 Partnerships, Collaborations, and Agreements:
  • 7.5 Bausch Health Companies, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Partnerships, Collaborations, and Agreements:
  • 7.6 Clearside Biomedical, Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Research & Development Expense
    • 7.6.4 Recent strategies and developments:
      • 7.6.4.1 Partnerships, Collaborations, and Agreements:
  • 7.7 EyePoint Pharmaceuticals, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Product Launches and Product Expansions:
      • 7.7.5.2 Acquisition and Mergers:
  • 7.8 Santen Pharmaceutical Co., Ltd.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Partnerships, Collaborations, and Agreements:
  • 7.9 Topivert Ltd.
    • 7.9.1 Company Overview
  • 7.1 Novartis AG
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Recent strategies and developments:
      • 7.10.4.1 Acquisition and Mergers:
      • 7.10.4.2 Approvals:
    • 7.10.5 Research & Development Expense

LIST OF TABLES

  • TABLE 1: GLOBAL UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 2: GLOBAL UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 3: GLOBAL UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 4: GLOBAL UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 5: GLOBAL ANTI-INFLAMMATORY MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 6: GLOBAL ANTI-INFLAMMATORY MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 7: GLOBAL IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 8: GLOBAL IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 9: GLOBAL ANTIMICROBIAL DRUGS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 10: GLOBAL ANTIMICROBIAL DRUGS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 11: GLOBAL OTHER DRUG CLASS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 12: GLOBAL OTHER DRUG CLASS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 13: GLOBAL UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 14: GLOBAL UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 15: GLOBAL ANTERIOR UVEITIS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 16: GLOBAL ANTERIOR UVEITIS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 17: GLOBAL POSTERIOR UVEITIS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 18: GLOBAL POSTERIOR UVEITIS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 19: GLOBAL INTERMEDIATE UVEITIS MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 20: GLOBAL INTERMEDIATE UVEITIS MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 21: GLOBAL OTHER DISEASES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 22: GLOBAL OTHER DISEASES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 23: GLOBAL UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 24: GLOBAL UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 25: GLOBAL HOSPITAL PHARMACIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 26: GLOBAL HOSPITAL PHARMACIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 27: GLOBAL RETAIL PHARMACIES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 28: GLOBAL RETAIL PHARMACIES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 29: GLOBAL ONLINE STORES MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 30: GLOBAL ONLINE STORES MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 31: GLOBAL UVEITIS TREATMENT MARKET BY REGION, 2015 - 2018, USD MILLION
  • TABLE 32: GLOBAL UVEITIS TREATMENT MARKET BY REGION, 2019 - 2025, USD MILLION
  • TABLE 33: NORTH AMERICA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 34: NORTH AMERICA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 35: NORTH AMERICA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 36: NORTH AMERICA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 37: NORTH AMERICA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 38: NORTH AMERICA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 39: NORTH AMERICA IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 40: NORTH AMERICA IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 41: NORTH AMERICA ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 42: NORTH AMERICA ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 43: NORTH AMERICA OTHER DRUG CLASS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 44: NORTH AMERICA OTHER DRUG CLASS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 45: NORTH AMERICA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 46: NORTH AMERICA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 47: NORTH AMERICA ANTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 48: NORTH AMERICA ANTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 49: NORTH AMERICA POSTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 50: NORTH AMERICA POSTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 51: NORTH AMERICA INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 52: NORTH AMERICA INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 53: NORTH AMERICA OTHER DISEASE TYPES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 54: NORTH AMERICA OTHER DISEASE TYPES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 55: NORTH AMERICA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 56: NORTH AMERICA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 57: NORTH AMERICA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 58: NORTH AMERICA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 59: NORTH AMERICA RETAIL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 60: NORTH AMERICA RETAIL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 61: NORTH AMERICA ONLINE STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 62: NORTH AMERICA ONLINE STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 63: NORTH AMERICA UVEITIS TREATMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 64: NORTH AMERICA UVEITIS TREATMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 65: USA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 66: USA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 67: USA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 68: USA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 69: USA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 70: USA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 71: USA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 72: USA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 73: CANADA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 74: CANADA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 75: CANADA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 76: CANADA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 77: CANADA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 78: CANADA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 79: CANADA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 80: CANADA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 81: MEXICO UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 82: MEXICO UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 83: MEXICO UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 84: MEXICO UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 85: MEXICO UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 86: MEXICO UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 87: MEXICO UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 88: MEXICO UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 89: REST OF NORTH AMERICA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 90: REST OF NORTH AMERICA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 91: REST OF NORTH AMERICA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 92: REST OF NORTH AMERICA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 93: REST OF NORTH AMERICA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 94: REST OF NORTH AMERICA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 95: REST OF NORTH AMERICA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 96: REST OF NORTH AMERICA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 97: EUROPE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 98: EUROPE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 99: EUROPE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 100: EUROPE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 101: EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 102: EUROPE ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 103: EUROPE IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 104: EUROPE IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 105: EUROPE ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 106: EUROPE ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 107: EUROPE OTHER DRUG CLASS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 108: EUROPE OTHER DRUG CLASS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 109: EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 110: EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 111: EUROPE ANTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 112: EUROPE ANTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 113: EUROPE POSTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 114: EUROPE POSTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 115: EUROPE INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 116: EUROPE INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 117: EUROPE OTHER DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 118: EUROPE OTHER DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 119: EUROPE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 120: EUROPE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 121: EUROPE HOSPITAL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 122: EUROPE HOSPITAL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 123: EUROPE RETAIL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 124: EUROPE RETAIL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 125: EUROPE ONLINE STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 126: EUROPE ONLINE STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 127: EUROPE UVEITIS TREATMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 128: EUROPE UVEITIS TREATMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 129: GERMANY UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 130: GERMANY UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 131: GERMANY UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 132: GERMANY UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 133: GERMANY UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 134: GERMANY UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 135: GERMANY UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 136: GERMANY UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 137: UK UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 138: UK UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 139: UK UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 140: UK UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 141: UK UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 142: UK UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 143: UK UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 144: UK UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 145: FRANCE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 146: FRANCE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 147: FRANCE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 148: FRANCE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 149: FRANCE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 150: FRANCE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 151: FRANCE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 152: FRANCE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 153: RUSSIA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 154: RUSSIA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 155: RUSSIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 156: RUSSIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 157: REST OF EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 158: RUSSIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 159: RUSSIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 160: RUSSIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 161: SPAIN UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 162: SPAIN UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 163: SPAIN UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 164: SPAIN UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 165: SPAIN UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 166: SPAIN UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 167: SPAIN UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 168: SPAIN UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 169: ITALY UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 170: ITALY UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 171: ITALY UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 172: ITALY UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 173: REST OF EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 174: ITALY UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 175: ITALY UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 176: ITALY UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 177: REST OF EUROPE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 178: REST OF EUROPE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 179: REST OF EUROPE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 180: REST OF EUROPE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 181: REST OF EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 182: REST OF EUROPE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 183: REST OF EUROPE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 184: REST OF EUROPE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 185: ASIA PACIFIC UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 186: ASIA PACIFIC UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 187: ASIA PACIFIC UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 188: ASIA PACIFIC UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 189: ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 190: ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 191: ASIA PACIFIC IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 192: ASIA PACIFIC IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 193: ASIA PACIFIC ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 194: ASIA PACIFIC ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 195: ASIA PACIFIC OTHER DRUG CLASS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 196: ASIA PACIFIC OTHER DRUG CLASS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 197: ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 198: ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 199: ASIA PACIFIC ANTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 200: ASIA PACIFIC ANTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 201: ASIA PACIFIC POSTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 202: ASIA PACIFIC POSTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 203: ASIA PACIFIC INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 204: ASIA PACIFIC INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 205: ASIA PACIFIC OTHER DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 206: ASIA PACIFIC OTHER DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 207: ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 208: ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 209: ASIA PACIFIC HOSPITAL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 210: ASIA PACIFIC HOSPITAL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 211: ASIA PACIFIC RETAIL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 212: ASIA PACIFIC RETAIL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 213: ASIA PACIFIC ONLINE STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 214: ASIA PACIFIC ONLINE STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 215: ASIA PACIFIC UVEITIS TREATMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 216: ASIA PACIFIC UVEITIS TREATMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 217: CHINA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 218: CHINA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 219: CHINA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 220: CHINA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 221: CHINA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 222: CHINA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 223: CHINA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 224: CHINA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 225: JAPAN UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 226: JAPAN UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 227: JAPAN UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 228: JAPAN UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 229: JAPAN UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 230: JAPAN UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 231: JAPAN UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 232: JAPAN UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 233: INDIA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 234: INDIA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 235: INDIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 236: INDIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 237: INDIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 238: INDIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 239: INDIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 240: INDIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 241: SOUTH KOREA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 242: SOUTH KOREA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 243: SOUTH KOREA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 244: SOUTH KOREA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 245: SOUTH KOREA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 246: SOUTH KOREA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 247: SOUTH KOREA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 248: SOUTH KOREA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 249: SINGAPORE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 250: SINGAPORE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 251: SINGAPORE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 252: SINGAPORE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 253: SINGAPORE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 254: SINGAPORE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 255: SINGAPORE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 256: SINGAPORE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 257: MALAYSIA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 258: MALAYSIA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 259: MALAYSIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 260: MALAYSIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 261: MALAYSIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 262: MALAYSIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 263: MALAYSIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 264: MALAYSIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 265: REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 266: REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 267: REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 268: REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 269: REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 270: REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 271: REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 272: REST OF ASIA PACIFIC UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 273: LAMEA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 274: LAMEA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 275: LAMEA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 276: LAMEA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 277: LAMEA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 278: LAMEA ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 279: LAMEA IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 280: LAMEA IMMUNOTHERAPY & TARGETED THERAPIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 281: LAMEA ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 282: LAMEA ANTIMICROBIAL DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 283: LAMEA OTHER DRUG CLASS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 284: LAMEA OTHER DRUG CLASS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 285: LAMEA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 286: LAMEA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 287: LAMEA ANTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 288: LAMEA ANTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 289: LAMEA POSTERIOR UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 290: LAMEA POSTERIOR UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 291: LAMEA INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 292: LAMEA INTERMEDIATE UVEITIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 293: LAMEA OTHER DISEASES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 294: LAMEA OTHER DISEASES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 295: LAMEA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 296: LAMEA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 297: LAMEA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 298: LAMEA HOSPITAL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 299: LAMEA RETAIL PHARMACIES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 300: LAMEA RETAIL PHARMACIES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 301: LAMEA ONLINE STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 302: LAMEA ONLINE STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 303: LAMEA UVEITIS TREATMENT MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 304: LAMEA UVEITIS TREATMENT MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 305: BRAZIL UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 306: BRAZIL UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 307: BRAZIL UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 308: BRAZIL UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 309: BRAZIL UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 310: BRAZIL UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 311: BRAZIL UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 312: BRAZIL UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 313: ARGENTINA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 314: ARGENTINA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 315: ARGENTINA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 316: ARGENTINA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 317: ARGENTINA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 318: ARGENTINA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 319: ARGENTINA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 320: ARGENTINA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 321: UAE UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 322: UAE UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 323: UAE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 324: UAE UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 325: UAE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 326: UAE UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 327: UAE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 328: UAE UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 329: SAUDI ARABIA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 330: SAUDI ARABIA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 331: SAUDI ARABIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 332: SAUDI ARABIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 333: SAUDI ARABIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 334: SAUDI ARABIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 335: SAUDI ARABIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 336: SAUDI ARABIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 337: SOUTH AFRICA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 338: SOUTH AFRICA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 339: SOUTH AFRICA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 340: SOUTH AFRICA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 341: SOUTH AFRICA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 342: SOUTH AFRICA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 343: SOUTH AFRICA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 344: SOUTH AFRICA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 345: NIGERIA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 346: NIGERIA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 347: NIGERIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 348: NIGERIA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 349: NIGERIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 350: NIGERIA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 351: NIGERIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 352: NIGERIA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 353: REST OF LAMEA UVEITIS TREATMENT MARKET, 2015 - 2018, USD MILLION
  • TABLE 354: REST OF LAMEA UVEITIS TREATMENT MARKET, 2019 - 2025, USD MILLION
  • TABLE 355: REST OF LAMEA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 356: REST OF LAMEA UVEITIS TREATMENT MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 357: REST OF LAMEA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2015 - 2018, USD MILLION
  • TABLE 358: REST OF LAMEA UVEITIS TREATMENT MARKET BY DISEASE TYPE, 2019 - 2025, USD MILLION
  • TABLE 359: REST OF LAMEA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 360: REST OF LAMEA UVEITIS TREATMENT MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 361: KEY INFORMATION - ABBVIE, INC.
  • TABLE 362: KEY INFORMATION - ALIMERA SCIENCES, INC.
  • TABLE 363: KEY INFORMATION - ENZO BIOCHEM, INC.
  • TABLE 364: KEY INFORMATION - AMGEN, INC.
  • TABLE 365: KEY INFORMATION - BAUSCH HEALTH COMPANIES, INC.
  • TABLE 366: KEY INFORMATION - CLEARSIDE BIOMEDICAL, INC.
  • TABLE 367: KEY INFORMATION - EYEPOINT PHARMACEUTICALS, INC.
  • TABLE 368: KEY INFORMATION - SANTEN PHARMACEUTICAL CO., LTD.
  • TABLE 369: KEY INFORMATION - TOPIVERT LTD.
  • TABLE 370 : KEY INFORMATION - NOVARTIS AG

LIST OF FIGURES

  • FIG 1: METHODOLOGY FOR THE RESEARCH